Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.10.2024 · 327 (4) · G558-G570
DOI: 10.1152/ajpgi.00147.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.10.2024. Verfasst von Sasha A S Kjeldsen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glucagon, Body Mass Index, Fatty Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Novo Nordisk Fonden (NNF), European Foundation for the Study of Diabetes (EFSD), Sundhed og Sygdom, Det Frie Forskningsråd (FSS, DFF).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) present with increased plasma levels of glucagon (hyperglucagonemia), irrespective of body mass index (BMI) and type 2 diabetes. Therefore, MASLD and the resultant hyperglucagonemia may act as a diabetogenic risk factor. Notably, hepatic steatosis was a significant contributor to the hyperglucagonemia in MASLD, potentially unveiling a pathway for the hyperglucagonemia in some patients with type 2 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark.
- Gastro Unit, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
- Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Pathology, Copenhagen University Hospital, Amager and Hvidovre, Hvidovre, Denmark.
ORCID-Profile: Sasha A S Kjeldsen, Josephine Grandt, Michael M Richter, Anne-Sofie H Jensen, Marie Winther-Sørensen, Nicolai J Wewer Albrechtsen
Förderung
- Novo Nordisk Fonden (NNF)
- European Foundation for the Study of Diabetes (EFSD)
- Sundhed og Sygdom, Det Frie Forskningsråd (FSS, DFF)
Zitieren
APA
Kjeldsen, S. A. S., Werge, M. P., Grandt, J., Richter, M. M., Thing, M., Hetland, L. E., Rashu, E. B., Jensen, A. H., Winther-Sørensen, M., Kellemann, J. S., Holst, J. J., Junker, A. E., Serizawa, R. R., Vyberg, M., Gluud, L. L., & Wewer Albrechtsen, N. J. (2024). Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 327(4), G558-G570. https://doi.org/10.1152/ajpgi.00147.2024
Vancouver
Kjeldsen SAS, Werge MP, Grandt J, Richter MM, Thing M, Hetland LE, et al. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;327(4):G558-G570. doi:10.1152/ajpgi.00147.2024
BibTeX
@article{Kjeldsen2024,
author = {Kjeldsen, Sasha A S and Werge, Mikkel P and Grandt, Josephine and Richter, Michael M and Thing, Mira and Hetland, Liv E and Rashu, Elias B and Jensen, Anne-Sofie H and Winther-Sørensen, Marie and Kellemann, Jesper Sloth and Holst, Jens J and Junker, Anders E and Serizawa, Reza R and Vyberg, Mogens and Gluud, Lise Lotte and Wewer Albrechtsen, Nicolai J},
title = {Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
volume = {327},
number = {4},
pages = {G558--G570},
doi = {10.1152/ajpgi.00147.2024}
}
EUVIMED